NEW YORK (GenomeWeb) ─ Genomic Health reported after the close of the market Wednesday that its fourth quarter revenues rose 8 percent year over year as the firm reported a 12 percent increase in Oncotype DX test results delivered during the quarter.

For the three months ended Dec. 31, Genomic Health's product revenues rose to $74.5 million from $69.1 million in the same period last year.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Researchers have sequenced the northern white rhinoceros to gauge whether it could be brought back from the edge of extinction, the New York Times reports.

Bavaria expands its forensic genetic analyses to include DNA phenotyping, raising discrimination concerns.

Tufts University researchers found a role for miRNA in transmitting stress between generations, the Economist reports.

In Science this week: gut microbiome influences liver cancer growth, spread; and more.